The state of New Jersey is taking aim at a subsidiary of Johnson & Johnson over opioids. State officials filed a lawsuit against Janssen Pharmaceutical claiming the company minimized the risk of addiction as it marketed the pain treatments.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,